Gateway Blog

Gateway Blog

Liquid Biopsy Successfully Detects Best Drugs for Treating Lung Cancer

By Admin at 20 May 2016

Along with being less invasive and safer than surgical biopsy, the liquid biopsy is faster, returning results in just three days compared to four weeks for surgical biopsy. The liquid biopsy blood test was also able to correctly identify the genetic mutations every time, allowing the oncologists to select the best targeted treatment and avoid repeat biopsies.

0 comments posted

Newly Discovered Lung Cancer ‘Driver Mutations’ May Respond to Immunotherapy

By Admin at 16 May 2016

Together, U.S. and Russian researchers have identified several driver mutations for lung cancer, which they believe may be responsive to targeted therapies and immunotherapy.

0 comments posted

Air Pollution Raises Cancer Death Risk by 22 Percent

By Admin at 13 May 2016

New research involving residents of Hong Kong found that long-term exposure to fine particles of air pollution—the type released from vehicles, power plants and manufacturing facilities—may increase your risk of dying from multiple types of cancer.

0 comments posted

Cholesterol-Lowering Drugs May Fight Lung Cancer

By Admin at 9 Mar 2016

Statins have been reported to reduce the incidence of lung cancer and also increase the survival of patients with lung cancer.

0 comments posted

Lung Cancer Kills More U.S. Women Than Any Other Cancer

By Admin at 23 Nov 2015

Many are surprised that lung cancer is the leading cancer killer among women, because breast cancer is more common. However, although lung cancer is the second most common cancer (excluding skin cancer and trailing prostate cancer in men and breast cancer in women), it’s far deadlier than breast cancer.

0 comments posted

    Categories

    Archive

    2018 2017 2016 2015
    99 cents of every dollar received directly funds cancer clinical trials

    58

    Current Gateway-funded clinical trials

    150+

    Clinical trials funded at leading institutions worldwide

    $16.56

    Funds one patient for one day at a Gateway-funded clinical trial

     
     

    Mission Partners